Arbele is a biotech and biopharmaceutical company focused on invention of proprietary immunotherapeutic platforms to accelerate the development of “first-in-class” antibody-based biologics to treat gastrointestinal cancers, in particular, stomach, pancreas, colon, bile duct and liver, which remain of high mortality and with limited treatment options.
Our Philosophy
Social Impact
Our business is to maximize availability of more effective cancer treatments for greater global health
Health Enhancement
To deliver "combination" immunotherapeutics possessing multiple anti-tumor mechanisms that are curative, or substantially prolong survival and improve quality of life
Breakthrough Innovation
Data driven research and proprietary discovery platforms to develop the safest products with the highest therapeutic potential